Your CDMO Pharmaceutical Partner
Sterling provides full-service API development, scale up and cGMP contract manufacturing services from grams to tonnes, combined with Antibody Drug Conjugate (ADC) research and development bioconjugation services.
Our vision is to deliver an exceptional experience to our customers and employees, setting a new standard of collaboration for the pharmaceutical industry, with scientific partnership at its core. Click here to read more about our vision and values.
Sterling Acquires UK Contract Research Organisation, NewChem Technologies
The importance of a seasoned commercial partner: Successfully scaling your product
Small Molecule
For more than 50 years, we have delivered comprehensive small molecule API development and manufacturing solutions to leading pharmaceutical and biotechnology organisations.
ADC
Drawing upon years of experience working with ADCs from their earliest inception, our dedicated bioconjugation team is committed to supporting your project from discovery to preclinical scale up.
